{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:16:46Z","timestamp":1773285406405,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ygyno.2013.01.024","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T20:33:44Z","timestamp":1360010024000},"page":"92-96","source":"Crossref","is-referenced-by-count":33,"title":["Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor"],"prefix":"10.1016","volume":"129","author":[{"given":"Francesco","family":"Raspagliesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2013.01.024_bb0005","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/IGC.0b013e31821ce75d","article-title":"First-line therapy in ovarian cancer trials","volume":"21","author":"Thigpen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.024_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Gynecologic Oncology Group. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.024_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","article-title":"The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer","volume":"112","author":"Lim","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2009.04.009","article-title":"Total colectomy as part of primary cytoreductive surgery in advanced Mullerian cancer","volume":"114","author":"Song","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0025","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2007.11.004","article-title":"Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer","volume":"108","author":"Salani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0040","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.024_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2010.12.350","article-title":"Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer","volume":"121","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.024_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2010.12.328","article-title":"Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer","volume":"121","author":"Martinez","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.024_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2012.05.036","article-title":"Resection of tumor from the supragastric lesser sac with peritonectomy","volume":"127","author":"Veerapong","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0060","series-title":"Anatomy of the Human Body","author":"Gray","year":"2000"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1023791229361","article-title":"Intraperitoneal cancer dissemination: mechanisms of the patterns of spread","volume":"22","author":"Pablo Carmignani","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0085","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0090","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0095","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.024_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygyno.2007.10.022","article-title":"The effect of maximal surgical cytoreduction on sensitivity to platinum\u2013taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer","volume":"108","author":"Eisenhauer","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.01.024_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.01.024_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T06:54:14Z","timestamp":1562655254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090825813000619"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}